NBIX: Neurocrine Biosciences, Inc. Stock

by  •  • Comments Off on NBIX: Neurocrine Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 12,440.71
Enterprise Value ($M) 12,091.61
Book Value ($M) 2,718.90
Book Value / Share 26.85
Price / Book 4.58
NCAV ($M) 1,060.50
NCAV / Share 10.47
Price / NCAV 11.73

Profitability (mra)
Return on Invested Capital (ROIC) 0.13
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.19

Liquidity (mrq)
Quick Ratio 4.26
Current Ratio 4.37

Balance Sheet (mrq) ($M)
Current Assets 1,876.60
Assets 3,535.00
Liabilities 816.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-17 13G State Street Corp 5.10
02-13 13G/A Vanguard Group Inc 9.88 3.96
01-23 13G/A BlackRock, Inc. 13.90 8.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-09 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 174,840 1,041,475 16.79
2024-11-14 112,809 736,297 15.32
2024-11-13 116,943 667,425 17.52
2024-11-12 180,823 704,628 25.66
2024-11-11 224,769 1,073,288 20.94

(click for more detail)

Similar Companies
MRSN – Mersana Therapeutics, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MYGN – Myriad Genetics, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc.


Financial data and stock pages provided by
Fintel.io